ConAgra Falls Short On Q4 Revenue Amid Unfavorable Price Mix ConAgra Brands, Inc. (NYSE:CAG) shares are trading lower on Thursday after the fourth-quarter results were reported. The company reported adjusted earnings per share of 61 cents, beating the analyst consensus estimate of 57 cents. Quarterly revenues of $2.905 billion missed the street view of $2.930 billion. The company’s reported net sales decreased by 2.3% and organic net sales decreased by 2.4%. ConAgra said that the decrease was driven by a 0.6% negative impact from price/mix, largely due to the company’s strategic investments in the quarter, and a 1.8% decrease in volume, primarily due to continued lower consumption trends. Also See: Food Giants Pivot To Discounts And New Sizes Amid Decreased Spending by Low-Income Americans Gross margin increased 135 basis points to 27.7% in the quarter, and adjusted gross margin increased 62 basis points to 27.6%. Adjusted EBITDA, which includes equity method investment earnings and pension and postretirement non-service income, was $577 million in the quarter, ConAgra added. The company ended the year with net debt of $8.4 billion, representing an 8.5% reduction in net debt versus the prior year, resulting in a 3.37x net leverage ratio at fiscal year-end. “Looking ahead, we expect a gradual waning of the challenging industry trends seen throughout fiscal year 2024, as consumers adapt and establish new reference prices,” said Sean Connolly, president and chief executive officer. Dividend: ConAgra approved the continuation of the company’s annualized dividend rate of $1.40 per share. The company’s quarterly dividend payment of $0.35 per share will be paid on August 29 to stockholders of record as of the close of business on August 1. Outlook: ConAgra sees FY25 organic net sales to be down 1.5% to flat compared to fiscal 2024 and adjusted EPS between $2.60 and $2.65 versus the $2.63 estimate. The company’s FY25 adjusted operating margin is expected between 15.6% and 15.8%. The company also expects the cost of goods sold inflation to continue into fiscal 2025. Price Action: CAG shares are trading lower by 2.43% to $28.11 premarket at last check Thursday. Image via Shutterstock Read Next: Biden Administration Injects $1.7B into EV Manufacturing Facilities Of General Motors, Stellantis & More "ACTIVE INVESTORS' SECRET WEAPON" Supercharge Your Stock Market Game with the #1 "news & everything else" trading tool: Benzinga Pro - Click here to start Your 14-Day Trial Now! Get the latest stock analysis from Benzinga? CONAGRA BRANDS (CAG): Free Stock Analysis Report This article ConAgra Falls Short On Q4 Revenue Amid Unfavorable Price Mix originally appeared on Benzinga.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
ConAgra Falls Short On Q4 Revenue Amid Unfavorable Price Mix
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...